Follow the misadventures of the impulsive Cuphead and his cautious but persuadable brother Mugman in this animated series based on the hit video game.
Glory Star New Media Group Holdings Limited (NASDAQ: GSMG) ("Glory Star" or the "Company"), a leading digital media platform and content-driven e-commerce company in China, today announced that on March 22, 2023, it received a written notice (the "Notice") from the Listing Qualifications Department of The Nasdaq Stock Market ("Nasdaq") indicating that the Company is not in compliance with the minimum bid price requirement of US$1.00 per share under the Nasdaq Listing Rules (the "Listing Rules").
Vancouver, British Columbia--(Newsfile Corp. - March 24, 2023) - Flow Metals Corp. (CSE: FWM) ("Flow Metals" or the "Company") announces that pursuant to the option agreement dated March 23, 2019 to acquire the Sixtymile Property, it has entered into debt settlement agreements ("Settlement Agreements") to settle a portion of the annual advanced royalty payment in cash and Common shares of the Company. Pursuant to the Settlement Agreements, the Company has issued an aggregate of ...
Novo Nordisk stock popped Friday after higher doses of its popular drug, semaglutide, led to greater weight loss in diabetes patients.
Electric-vehicle maker Rivian Automotive Inc. is relocating parts of its manufacturing engineering team to its Illinois factory as part of a reorganization aimed at speeding up production.
Kiernan Shipka revealed that years ago she actually auditioned to play Primrose Everdeen in The Hunger Games movies.
The "Moana" star showed her support for missing and murdered indigenous women at a recent movie premiere
A California judge will allow expert testimony linking GSK's heartburn drug Zantac to cancer. The decision took a bite out of GSK stock Friday.
Wastewater from oil operations pumped into the ground sparked Alberta temblors, a regulator and a Stanford University study both concluded.
Incyte stock toppled Friday after the FDA unexpectedly rejected an extended-release version of its blockbuster drug, Jakafi.
Despite indications to the contrary, Netflix's crackdown on password sharing is likely to boost its subscriber count, a Wall Street analyst says.
Reese Witherspoon and Jim Toth said they are "moving forward with deep love, kindness" as they announced their divorce
Key Insights Shriro Holdings' estimated fair value is AU$0.58 based on 2 Stage Free Cash Flow to Equity Current share...
The Seahawks Spring Selfie Stretch continues in Lexington, KY
Nakesha Brown, who's attending a meeting at work, has no idea her son, Ezekeil, is sitting right across from her after two years away in the Navy.
The Tommy Bahama parent posted strong fourth-quarter results, but guidance showed that margins would narrow in 2023.
BOSTON, March 24, 2023--Karuna Therapeutics, Inc. (NASDAQ: KRTX) ("Karuna"), a clinical-stage biopharmaceutical company driven to create and deliver transformative medicines for people living with psychiatric and neurological conditions, today announced the closing of its previously announced underwritten public offering of 2,851,299 shares of common stock, which includes the exercise in full by the underwriters of their option to purchase an additional 371,908 shares, at the public offering pri
Vancouver, British Columbia--(Newsfile Corp. - March 24, 2023) - Equinox Gold Corp. (TSX: EQX) (NYSE American: EQX) ("Equinox Gold" or the "Company") will hold its annual general meeting of shareholders ("Annual Meeting") on Wednesday, May 3, 2023 commencing at 1:30 pm Vancouver time, followed by a corporate update commencing at 1:45 pm. Shareholders who cannot attend the Annual Meeting or the corporate update in person are invited to join online.Information regarding how to participate ...
The brokerage’s stock has plunged by more than a third this year as customers yank cash from low-yielding “sweep” accounts. What’s ahead.
First TIL Therapy BLA Submission to U.S. Food and Drug AdministrationSAN CARLOS, Calif., March 24, 2023 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a late-stage biotechnology company developing novel T cell-based cancer immunotherapies, today announced it has completed its rolling Biologics License Application (BLA) submission to the U.S. Food and Drug Administration (FDA) for lifileucel. Lifileucel is a tumor infiltrating lymphocyte (TIL) therapy intended as a treatment fo
Yahoo Home